: Case Ⅰ: 3DMed: An R&D Platform for Personalised Precision Anti-cancer Drugs Overview of Anti-cancer Drug R&D History of Anti-cancer Drug R&D From R&D to Launch The Biopharmaceutical Industry Chain Analysis of Global Market Potential Analysis of Chinese Market Potential The Start-Up Decision The Early Years: Accumulating Knowledge Forecast of Market Trends Back to the Homeland The Start-Up‘s Focus Individualised Precision Treatment Large-Scale Drug Screening Model Next-Generation Sequencing (NGS) Big Data Processing The Start-Up Process Founding the Company The Entrepreneurial Team Accumulating Resources Angel Round of Financing Technological In ...
以下为对购买帮助不大的评价